| HealthPartners | Oncology - trastuzumab (Herceptin®, Herzuma®, | 2026-07-01 |
| HealthPartners | Oncology** - rituximab (Rituxan®, Ruxience™, | 2026-07-01 |
| HealthPartners | Oncology** - rituximab (Rituxan®, Ruxience™, | 2026-07-01 |
| HealthPartners | Pegloticase (Krystexxa®) | 2026-07-01 |
| HealthPartners | Preventive care services | 2026-07-01 |
| HealthPartners | Recent Food and Drug Administration (FDA) approved | 2026-07-01 |
| HealthPartners | Reproductive testing: carrier screening | 2026-07-01 |
| HealthPartners | Reproductive testing: fertility | 2026-07-01 |
| HealthPartners | Romosozumab-aqqg (Evenity®) | 2026-07-01 |
| HealthPartners | Somatostatin analogues for acromegaly (Sandostatin | 2026-07-01 |